by Society for Academic Emergency Medicine

Low-dose ketamine shows promise for pain relief in emergency department patients

Pain intensity scores during the study period. The median is represented by the bold horizontal line within the box. The box defines the IQR. LDK, low-dose ketamine; NRS, Numeric Rating Scale. Credit: Academic Emergency Medicine (2024). DOI: 10.1111/acem.14983

A study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the Academic Emergency Medicine journal.

The study, titled "Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use," highlights the potential of low-dose ketamine as a valuable tool in pain management, providing a safe and effective option for emergency medicine physicians managing acute pain.

Pain remains one of the most common and challenging complaints among patients presenting to the emergency department (ED). For individuals with opioid tolerance, achieving effective pain relief can be particularly difficult, as they often require higher doses of opioids, which increases risks of hyperalgesia and withdrawal symptoms.

In their randomized, placebo-controlled trial, lead author Stine Fjendbo Galili, MD, and colleagues explored the effectiveness of LDK as an adjunct to morphine in a diverse ED population with varying levels of opioid use. The study demonstrated that a single dose of 0.1 mg/kg of ketamine provided significant reductions in pain scores for 30 minutes compared to a placebo.

The study concluded that LDK may be an effective short-term adjunct analgesic to morphine for managing acute pain, offering relief to both opioid-tolerant and opioid-naïve patients. Importantly, the findings open the door for future research to refine low-dose ketamine administration methods, such as bolus or continuous infusions, to achieve longer-lasting pain relief.

More information: Stine Fjendbo Galili et al, Low‐dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use, Academic Emergency Medicine (2024). DOI: 10.1111/acem.14983

Journal information: Academic Emergency Medicine 

Provided by Society for Academic Emergency Medicine